68Ga-DTPA Anti-HER2 positron emission tomography/CT successfully predicts the overexpression of human epidermal growth factor receptor in lung metastases from breast cancer.
-
Authors
-
-
Pitalúa-Cortés, Quetzali Gabriela1
-
García-Pérez, Francisco O1
-
Villaseñor-Navarro, Yolanda2
-
Lara-Medina, Fernando Ulises1
-
Matus-Santos, Juan Antonio3
-
Soldevilla-Gallardo, Irma1
-
Porras-Reyes, Fany Iris4
-
Pérez-Sánchez, Victor Manuel4
-
Maldonado-Martínez, Héctor Aquiles4
-
Pérez-Báez, Wendy4
-
Sollozo-Dupont, Isabel1
-
1
Deparment of Nuclear Medicine, Instituto Nacional de Cancerología, INCan, México.
-
2
Department of Radiology and Imaging, Instituto Nacional de Cancerología, INCan, México.
-
3
Deparment of Medical Oncology, Instituto Nacional de Cancerología, INCan, México.
-
4
Deparment of Surgical Pathology, Instituto Nacional de Cancerología, INCan, México.
- Type
- Published Article
- Journal
-
BJR case reports
- Publication Date
-
Jan 01, 2017
- Volume
-
3
- Issue
-
3
- Pages
-
20160136–20160136
- Identifiers
-
DOI: 10.1259/bjrcr.20160136
-
PMID: 30363270
- Source
-
Medline
- Language
-
English
- License
-
Unknown
Abstract
Molecular identification of a metastatic tumour without the inconvenience of a biopsy and the time required for pathological characterization is possible using molecular imaging. Here, we present the case of a patient with breast cancer in whom 68Ga-diethylenetriamine pentaacetic acid anti-human epidermal growth factor receptor 2 positron emission tomography-CT was successfully employed to characterize the expression of human epidermal growth factor receptor 2 in metastatic sites.
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 10/22/2019 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at
https://www.ncbi.nlm.nih.gov/pubmed/30363270
